FET F-18
- Generic Name
- FET F-18
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H14FNO3
- CAS Number
- 178433-03-9
- Unique Ingredient Identifier
- 1326R5J1IA
- Background
FET F-18 is under investigation in clinical trial NCT01756352 (FET-PET for Evaluation of Response of Recurrent GBM to Avastin).
- Associated Conditions
- -
- Associated Therapies
- -
Registering Genomics and Imaging of Tumors (ReGIT)
- First Posted Date
- 2022-05-23
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 20
- Registration Number
- NCT05386043
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
FET-PET for Evaluation of Response of Recurrent GBM to Avastin
- First Posted Date
- 2012-12-25
- Last Posted Date
- 2019-10-30
- Lead Sponsor
- Marcelo F. Di Carli, MD, FACC
- Target Recruit Count
- 13
- Registration Number
- NCT01756352
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath